Zenovel Pharma Services LLP

Risk Based

Risk Based Monitoring Approach

Efficient Clinical Research Monitoring is critical for protecting the well-being of trial participants and maintaining the integrity of final results. It is now globally accepted that the process for clinical trial monitoring needs to be changed from the conventional approach to Risk-based Monitoring in Clinical trials. The risk-Based Monitoring Approach is now the preferred method for monitoring clinical trials and Bioequivalence Studies.

Initially, FDA has introduced the concept of monitoring in clinical research to oversee the compliance and integrity of overall trial conduct. However, ICH has taken this to a very advanced level by introducing the Risk-Based Monitoring Approach during Clinical Trial/Clinical Research including Bioequivalence Studies and all kinds of studies involving human participants.

The Risk-Based Monitoring Approach specifically focuses more on the areas where there is a higher chance of error and which may lead to failure of the trial, compromise of safety and waste of resources.

Later on, EMA also published the reflection paper and supported the Risk-Based Approach during monitoring as a very essential tool to enhance the quality of conduct of the trial.

Advantage of RBM includes lower cost, fewer errors, better analysis, cross-site comparison, more timely result, improving patient safety and data quality and complying with regulatory requirements, which make RBM very essential nowadays.

With a highly experienced team, Zenovel is the most trusted and credible partner for many Pharmaceutical companies for overseeing the clinical trials and bioequivalence studies with an effective, focused and well planned Risked Based Approach of Monitoring. 

The Basic Purposes of Clinical Trial Monitoring:

Clinical Research Monitoring / Clinical Trial Monitoring is performed to verify,

Monitoring plan is the key document to be prepared specific to the trail and molecule. Monitoring plan will be covering the identification and selection of the monitor, training and delegation of monitors based on the experience, qualifications, scientific and/or clinical knowledge needed to monitor the Clinical Trial or Bioequivalence Study.


Monitor should be familiar with the investigational product(s), the protocol, written informed consent form and any other written information to be provided to subjects, the sponsor’s SOPs, GCP, and the applicable regulatory requirement(s).

Monitoring plan should also cover a list of key risks identified and the strategies on how to mitigate the same while monitoring.

Zenovel has a well-established SOP for Risk-Based Monitoring Approach to ensure the maximum compliance and integrity of the data during the conduct of Clinical Trial or Bioequivalence study.

Zenovel provides multiple tailor-made service packages which can be customized based on the study-specific requirements, study design, Risk Involved and based on the needs of clients. We always focus on the real requirement and all our efforts are inclined towards giving multiple choices to our clients to make it cost-effective yet quality-oriented.

From which sponsor can opt for their choice of the package (ZenSight, Zensure, Zenlife), to achieve their desired goal and end results.  

Services ZenSight ZenSure ZenLife
Pre-Trial Service CRO/ PI Selection
CRO Audit and Qualification
Protocol Preparation Support
Protocol Review
Method Development and Validation Verification
Pre-Approval Support
Investigator Meeting
During Trial Services Periodic Monitoring
Medico Monitoring Service
Quality Assurances Visit
For-Cause Investigation Visit
PK-State Data Review
Post Trial Services Retrospective Clinical Data Review
Retrospective BA Data Review
IMP Verification and Reconciliation
Stand Alone Services Readiness Audit
Project Management Services
SOP/Documents Review
Control Correspondence
Training on Medical Devise i.e., Inhaler
Sponsor Oversight
Bio viewer and other Regulatory Query responding

Monitoring of Bioequivalence Studies includes the below-mentioned visits

Clinical Trial and Monitoring


ROOT CAUSE ANALYSIS IN CLINICAL RESEARCH Clinical trials are intricate endeavors aimed at bringing...

Revolutionizing Clinical Trial Monitoring: The Power of Risk-Based Monitoring (RBM)

Abstract: For the past few years, regulatory bodies, industry advocacy groups, and private companies...

Mastering Inhalation Studies: A Closer Look at Challenges and Solutions

Introduction: In the realm of inhalation studies, achieving consistent compliance and accurate...

FAQ GxP Quality Guidelines

GxP Quality Guidelines and Regulations: Frequently Asked Questions: What happens when GxP...

Ensuring Data Integrity: Best Practices and Considerations

INTRODUCTION: There are multiple definitions of data integrity, yet the essence is the same. Data...

The Road to FDA Success: Zenovel’s Insights and Expertise

The Road to FDA Success: Zenovel’s Insights and Expertise Preparing for FDA interactions can...

GMP Audits Unveiled: Behind the Scenes of Ensuring Compliance

Understanding the role of GMP Audits and Its Importance Good Manufacturing Practices (GMP) are a set...

How to Prepare Subject Matter Experts for FDA Inspections

Introduction Facing an FDA inspection can be a nerve-wracking experience for any pharmaceutical...

Ace Your FDA Inspection with Zenovel

Ace Your FDA Inspection with Zenovel Understanding FDA Inspections Before we dive into the specifics...